Ticker > Company >

Divi''s Lab share price

Divi''s Laboratories Ltd.

NSE: DIVISLAB BSE: 532488 SECTOR: Pharmaceuticals & Drugs  4.37 L   2.74 K   689

6024.00
-6.35 (-0.11%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 6071.75

Today's Low

₹ 5986.05

52 Week High

₹ 7077.7

52 Week Low

₹ 4941.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

159918.27 Cr.

Enterprise Value

156224.27 Cr.

No. of Shares

26.55 Cr.

P/E

68.46

P/B

10.35

Face Value

₹ 2

Div. Yield

0.5 %

Book Value (TTM)

₹  582.07

CASH

3696 Cr.

DEBT

2 Cr.

Promoter Holding

51.89 %

EPS (TTM)

₹  88

Sales Growth

20%

ROE

15.57 %

ROCE

20.65%

Profit Growth

40.17 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Divi''s Laboratories Ltd.

Carotenoids Lutein Beta-Carotene Naproxen Dextromethorphan Gabapentin

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year20%
3 Year1.18%
5 Year11.61%

Profit Growth

1 Year40.16%
3 Year-9.18%
5 Year9.98%

ROE%

1 Year15.57%
3 Year14.14%
5 Year18.82%

ROCE %

1 Year20.65%
3 Year18.76%
5 Year24.6%

Debt/Equity

0.0001

Price to Cash Flow

96.92

Interest Cover Ratio

1465.5

CFO/PAT (5 Yr. Avg.)

0.878428125827676

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 51.89 0.00
Mar 2025 51.89 0.00
Dec 2024 51.89 0.00
Sep 2024 51.89 0.00
Jun 2024 51.90 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 1465.5.
  • The Company has been maintaining an effective average operating margins of 35.1638248200699% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 4.8693.
  • The company has a high promoter holding of 51.89%.

 Limitations

  • The company has shown a poor profit growth of -9.17691894564887% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.18039331826569% for the Past 3 years.
  • The company is trading at a high PE of 68.46.
  • The company is trading at a high EV/EBITDA of 44.725.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 2063 2302 2297 2536 2357
Total Expenditure 1442 1573 1550 1655 1614
Operating Profit 621 729 747 881 743
Other Income 79 105 82 87 119
Interest 0 1 0 0 3
Depreciation 97 98 99 107 112
Exceptional Items 0 0 0 0 0
Profit Before Tax 603 735 730 861 747
Tax 173 217 136 194 190
Profit After Tax 430 518 594 667 557
Adjusted EPS (Rs) 16.23 19.55 22.42 25.17 21.02

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 6798.61 8879.82 7625 7665 9198
Total Expenditure 3977.73 5005.05 5276 5490 6218
Operating Profit 2820.88 3874.77 2349 2175 2980
Other Income 63.45 114.03 349 337 352
Interest 1.81 1.73 2 4 2
Depreciation 254.65 310.55 342 376 401
Exceptional Items 0 0 0 0 0
Profit Before Tax 2627.87 3676.52 2354 2132 2929
Tax 673.15 727.98 546 556 720
Net Profit 1954.72 2948.54 1808 1576 2209
Adjusted EPS (Rs.) 73.64 111.08 68.23 59.47 83.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 53.09 53.09 53 53 53
Total Reserves 9218.48 11638.26 12652 13431 14842
Borrowings 0 0 0 0 0
Other N/C liabilities 363.48 448.11 568 619 509
Current liabilities 1704.78 2427.29 1511 1730 2212
Total Liabilities 11339.83 14566.75 14784 15833 17616
Assets
Net Block 3699.01 4320.97 4719 4737 5440
Capital WIP 710.62 469.93 212 778 1022
Intangible WIP 0 0 0 0 0
Investments 7.37 79.37 84 89 72
Loans & Advances 172.42 133.58 97 176 301
Other N/C Assets 9.21 8.05 4 10 10
Current Assets 6741.2 9554.85 9668 10043 10771
Total Assets 11339.83 14566.75 14784 15833 17616
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 2627.87 3676.52 2354 2132 2929
Adjustment 186.66 235.32 118 72 113
Changes in Assets & Liabilities -234.52 -1371.89 447 -565 -574
Tax Paid -632.96 -629.79 -472 -373 -818
Operating Cash Flow 1947.05 1910.16 2447 1266 1650
Investing Cash Flow 75.34 -2195.4 -2707 -268 -803
Financing Cash Flow -33.97 -531.5 -796 -798 -797
Net Cash Flow 1988.42 -816.74 -1056 200 50

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 51.90 51.89 51.89 51.89 51.89
madhusudana rao divi 0.08 0.07 0.07 0.07 0.07
murali krishna prasad div... 2.85 2.85 2.85 2.85 2.85
nilima prasad divi 20.34 20.34 20.34 20.34 20.34
satchandra kiran divi 20.34 20.34 20.34 20.34 20.34
swarna latha divi 5.27 5.27 5.27 5.27 5.27
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 48.10 48.11 48.11 48.11 48.11
axis mutual fund trustee ... 1.60 1.50 1.39 1.39 1.30
government of singapore - 1.77 2.38 2.26 2.64
government pension fund g... 1.63 1.53 1.34 1.32 1.35
hdfc mutual fund - - - - 1.01
investor education and pr... 0.01 - 0.01 - 0.01
life insurance corporatio... 6.73 6.95 6.03 5.63 3.94
nippon life india trustee... 1.07 1.18 1.18 1.20 1.16
sbi mutual fund 7.41 5.65 5.36 4.97 4.79
investor education and pr... - 0.01 - 0.01 -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research Geojit
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research Motilal Oswal
Research ICICI Securities Limited
Research BOB Capital Markets Ltd.

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q4FY21
Concall Q3FY25
Concall Q3FY24
Concall Q3FY21
Concall Q2FY22
Concall Q2FY21
Concall Q1FY25
Concall Q1FY23
Concall Q1FY22
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Divi''s Lab Stock Price Analysis and Quick Research Report. Is Divi''s Lab an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Divi''s Lab. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Divi''s Lab has a PE ratio of 68.3616056766668 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Divi''s Lab has ROA of 13.2082% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Divi''s Lab has a Current ratio of 4.8693.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Divi''s Lab has a ROE of 15.5678%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Divi''s Lab has a Debt to Equity ratio of 0.0001 which means that the company has low proportion of debt in its capital.

  • Sales growth: Divi''s Lab has reported revenue growth of 20% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Divi''s Lab for the current financial year is 32.3983474668406%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Divi''s Lab is Rs 30 and the yield is 0.4988%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Divi''s Lab is Rs 87.9953. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Divi''s Lab in Ticker for free. Also, one can get the intrinsic value of Divi''s Lab by using Valuation Calculators, which are available with a Finology ONE subscription. 

Divi''s Lab FAQs

Q1. What is Divi''s Lab share price today?
Ans: The current share price of Divi''s Lab is Rs 6015.5.

Q2. What is the market capitalisation of Divi''s Lab?
Ans: Divi''s Lab has a market capitalisation of Rs 159692.624299 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Divi''s Lab?
Ans: The PE ratio of Divi''s Lab is 68.3616056766668 and the P/B ratio of Divi''s Lab is 10.3346925087524, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Divi''s Lab share?
Ans: The 52-week high share price of Divi''s Lab is Rs 7071.5, and the 52-week low share price of Divi''s Lab is Rs 4955.

Q5. Does Divi''s Lab pay dividends?
Ans: Currently, Divi''s Lab pays dividends. Dividend yield of Divi''s Lab is around 0.4988%.

Q6. What are the face value and book value of Divi''s Lab shares?
Ans: The face value of Divi''s Lab shares is Rs 2, while the book value per share of Divi''s Lab is around Rs 582.0686. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Divi''s Lab?
Ans: Divi''s Lab has a total debt of Rs 2 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Divi''s Lab?
Ans: The ROE of Divi''s Lab is 15.5678% and ROCE of Divi''s Lab is 20.6547%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Divi''s Lab a good buy for the long term?
Ans: The Divi''s Lab long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Divi''s Lab undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Divi''s Lab appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Divi''s Lab’s financials?
Ans: You can review Divi''s Lab’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Divi''s Lab
X